ClinicalTrials HQ

Safety of a Boost (CXB or EBRT) in Combination With Neoadjuvant Chemoradiotherapy for Early Rectal Adenocarcinoma

Safety of a Boost (CXB or EBRT) in Combination With Neoadjuvant Chemoradiotherapy for Early Rectal Adenocarcinoma

Active, not recruiting · NCT02505750 · Registry updated 2025-09-29
Ask about research services

Clinical trials

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Safety of a Boost (CXB or EBRT) in Combination With Neoadjuvant Chemoradiotherapy for Early Rectal AdenocarcinomaDigestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, colorectal neoplasm, digestive system disorder, digestive system neoplasm, intestinal disorder, neoplasm, rectal disorder, rectal neoplasmActive, not recruitingPhase 32025-09-29NCT02505750

19 results · Page 1 of 1

18 results · Page 1 of 1

Research sites

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Centre Antoine LacassagneNiceFrance83
Centre d'oncologie et de radiothérapie MâconMâconFrance1
Centre de radiothérapie BayardVilleurbanneFrance1
Centre Jean GodinotReimsFrance1
Centre Léon BérardLyonFrance50
Christie HospitalManchesterUnited Kingdom1
CHRU BesançonBesançonFrance1
Clatterbridge Cancer Centre NHS Foundation TrustLiverpoolUnited Kingdom1
Clinique CharcotSainte-Foy-lès-LyonFrance2
Clinique de la SauvegardeLyonFrance1
Hospices Civils de Lyon - Centre Hospitalier Lyon-SudPierre-BéniteFrance1
Hôpital de la Croix Rouge Française - Centre de Radiothérapie St LouisToulonFrance1
Hôpitaux Universitaires de GenèveGenevaSwitzerland1
Institut de Cancérologie LUCIEN NEUWIRTHSaint-Priest-en-JarezFrance5
Institut Paoli CalmettesMarseilleFrance56
Royal Surrey County HospitalGuildfordUnited Kingdom8
Spire Hull and East Riding HospitalHullUnited Kingdom1
University HospitalNottinghamUnited Kingdom1